Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer
Condition:   Breast Cancer Intervention:   Sponsors:   Peking Union Medical College Hospital;   Peking University Third Hospital;   Beijing Hospital;   Beijing Chao Yang Hospital;   Beijing Zhongguancun Hospital;   Peking University Shouyang Hospital;   Beijing Aerospace Center Hospital;   Beijing Anzhen Community Health  Service Center;   The First Hospital of Tsinghua University;   Sun Yat-sen Hospital,&n...
Source: ClinicalTrials.gov - February 22, 2019 Category: Research Source Type: clinical trials

A Web-Based Tool to Improve Breast Cancer Survivorship
Conditions:   Breast Cancer;   Hormone Dependent Neoplasms;   Adherence to Hormone Therapy Interventions:   Behavioral: " OncoTool " Intervention (MBSR + HT education);   Behavioral: " Oncotool " Control (health +HT education) Sponsor:   Northwestern University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2019 Category: Research Source Type: clinical trials

Comorbidities and Health Care Services Utilisation Among Long-term Breast Cancer Survivors
Condition:   Breast Cancer Intervention:   Sponsors:   Parc de Salut Mar;   Fondo de Investigacion Sanitaria;   European Regional Development Fund;   Red de Investigación en Servicios de Salud y Enfermedades Crónicas (REDISSEC) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer
Conditions:   Breast Cancer;   Gastric/Gastroesophageal Junction Cancer Intervention:   Drug: KN026 Sponsor:   Jiangsu Alphamab Biopharmaceuticals Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Prospective Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis
Condition:   Breast Carcinoma Metastatic to the Bone Intervention:   Diagnostic Test: BOMET-QoL questionnaire Sponsors:   Spanish Breast Cancer Research Group;   Novartis Farmacéutica S.A Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
Conditions:   Breast Cancer;   Chronic Pain Due to Malignancy (Finding) Interventions:   Drug: Sulfasalazine;   Drug: Placebos Sponsor:   University of Arizona Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Effect of Preoperative Curcumin in Breast Cancer Patients
Condition:   Breast Cancer Interventions:   Dietary Supplement: Curcumin;   Other: Placebo Sponsor:   University of Malaya Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer
Condition:   HER2-positive Breast Cancer Intervention:   Drug: Pyrotinib+Trastuzumab+Docetaxel+Carboplatin Sponsor:   Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Comorbidities and Health Care Services Utilisation Among Long-term Breast Cancer Survivors
Condition:   Breast Cancer Intervention:   Sponsors:   Parc de Salut Mar;   Fondo de Investigacion Sanitaria;   European Regional Development Fund;   Red de Investigación en Servicios de Salud y Enfermedades Crónicas (REDISSEC) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer
Condition:   HER2-positive Breast Cancer Intervention:   Drug: Pyrotinib+Trastuzumab+Docetaxel+Carboplatin Sponsor:   Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Effect of Preoperative Curcumin in Breast Cancer Patients
Condition:   Breast Cancer Interventions:   Dietary Supplement: Curcumin;   Other: Placebo Sponsor:   University of Malaya Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
Conditions:   Breast Cancer;   Chronic Pain Due to Malignancy (Finding) Interventions:   Drug: Sulfasalazine;   Drug: Placebos Sponsor:   University of Arizona Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Prospective Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis
Condition:   Breast Carcinoma Metastatic to the Bone Intervention:   Diagnostic Test: BOMET-QoL questionnaire Sponsors:   Spanish Breast Cancer Research Group;   Novartis Farmacéutica S.A Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer
Conditions:   Breast Cancer;   Gastric/Gastroesophageal Junction Cancer Intervention:   Drug: KN026 Sponsor:   Jiangsu Alphamab Biopharmaceuticals Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
Conditions:   Breast Cancer;   Chronic Pain Due to Malignancy (Finding) Interventions:   Drug: Sulfasalazine;   Drug: Placebos Sponsor:   University of Arizona Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Prospective Study of the Utility of the BOMET-QOL Questionnaire Patients With Breast Cancer and Bone Metastasis
Condition:   Breast Carcinoma Metastatic to the Bone Intervention:   Diagnostic Test: BOMET-QoL questionnaire Sponsors:   Spanish Breast Cancer Research Group;   Novartis Farmacéutica S.A Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer
Conditions:   Breast Cancer;   Gastric/Gastroesophageal Junction Cancer Intervention:   Drug: KN026 Sponsor:   Jiangsu Alphamab Biopharmaceuticals Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Comorbidities and Health Care Services Utilisation Among Long-term Breast Cancer Survivors
Condition:   Breast Cancer Intervention:   Sponsors:   Parc de Salut Mar;   Fondo de Investigacion Sanitaria;   European Regional Development Fund;   Red de Investigación en Servicios de Salud y Enfermedades Crónicas (REDISSEC) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer
Condition:   HER2-positive Breast Cancer Intervention:   Drug: Pyrotinib+Trastuzumab+Docetaxel+Carboplatin Sponsor:   Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Effect of Preoperative Curcumin in Breast Cancer Patients
Condition:   Breast Cancer Interventions:   Dietary Supplement: Curcumin;   Other: Placebo Sponsor:   University of Malaya Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT
Condition:   Breast Cancer Intervention:   Drug: Imaging Drug FluorThanatrace (FTT) Sponsor:   University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2019 Category: Research Source Type: clinical trials

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen
Condition:   Breast Cancer Interventions:   Drug: Promensil;   Drug: Placebo Oral Tablet Sponsor:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2019 Category: Research Source Type: clinical trials

The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer
Condition:   Breast Cancer Intervention:   Sponsor:   Cancer Trials Ireland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2019 Category: Research Source Type: clinical trials

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen
Condition:   Breast Cancer Interventions:   Drug: Promensil;   Drug: Placebo Oral Tablet Sponsor:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2019 Category: Research Source Type: clinical trials

The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer
Condition:   Breast Cancer Intervention:   Sponsor:   Cancer Trials Ireland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2019 Category: Research Source Type: clinical trials

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen
Condition:   Breast Cancer Interventions:   Drug: Promensil;   Drug: Placebo Oral Tablet Sponsor:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2019 Category: Research Source Type: clinical trials

The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer
Condition:   Breast Cancer Intervention:   Sponsor:   Cancer Trials Ireland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2019 Category: Research Source Type: clinical trials

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen
Condition:   Breast Cancer Interventions:   Drug: Promensil;   Drug: Placebo Oral Tablet Sponsor:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2019 Category: Research Source Type: clinical trials

Clinical Application of CTC in Operable Breast Cancer Patients
Condition:   Breast Cancer Interventions:   Procedure: Neoadjuvant chemotherapy before surgery;   Procedure: Surgery followed by adjuvant chemotherapy Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Pembrolizumab;   Drug: Paclitaxel Sponsors:   Queen Mary University of London;   Merck Sharp & Dohme Corp.;   European Institute of Oncology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Combination Product: Docetaxel / Capecitabine;   Combination Product: Capecitabine / Vinorelbine;   Combination Product: Paclitaxel / Gemcitabine;   Drug: Ribociclib;   Drug: Letrozole OR Anastrozole;   Drug: Goserelin Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Clinical Application of CTC in Operable Breast Cancer Patients
Condition:   Breast Cancer Interventions:   Procedure: Neoadjuvant chemotherapy before surgery;   Procedure: Surgery followed by adjuvant chemotherapy Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Pembrolizumab;   Drug: Paclitaxel Sponsors:   Queen Mary University of London;   Merck Sharp & Dohme Corp.;   European Institute of Oncology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Combination Product: Docetaxel / Capecitabine;   Combination Product: Capecitabine / Vinorelbine;   Combination Product: Paclitaxel / Gemcitabine;   Drug: Ribociclib;   Drug: Letrozole OR Anastrozole;   Drug: Goserelin Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Pembrolizumab;   Drug: Paclitaxel Sponsors:   Queen Mary University of London;   Merck Sharp & Dohme Corp.;   European Institute of Oncology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Clinical Application of CTC in Operable Breast Cancer Patients
Condition:   Breast Cancer Interventions:   Procedure: Neoadjuvant chemotherapy before surgery;   Procedure: Surgery followed by adjuvant chemotherapy Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Pembrolizumab;   Drug: Paclitaxel Sponsors:   Queen Mary University of London;   Merck Sharp & Dohme Corp.;   European Institute of Oncology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Combination Product: Docetaxel / Capecitabine;   Combination Product: Capecitabine / Vinorelbine;   Combination Product: Paclitaxel / Gemcitabine;   Drug: Ribociclib;   Drug: Letrozole OR Anastrozole;   Drug: Goserelin Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Clinical Application of CTC in Operable Breast Cancer Patients
Condition:   Breast Cancer Interventions:   Procedure: Neoadjuvant chemotherapy before surgery;   Procedure: Surgery followed by adjuvant chemotherapy Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Pembrolizumab;   Drug: Paclitaxel Sponsors:   Queen Mary University of London;   Merck Sharp & Dohme Corp.;   European Institute of Oncology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
Condition:   Breast Cancer Interventions:   Combination Product: Docetaxel / Capecitabine;   Combination Product: Capecitabine / Vinorelbine;   Combination Product: Paclitaxel / Gemcitabine;   Drug: Ribociclib;   Drug: Letrozole OR Anastrozole;   Drug: Goserelin Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials